Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
KYTX on Nasdaq
There are no Buy or Sell transactions made by Westlake BioPartners Fund I, L.P. since 30 Jan 2025
Holdings reported by Westlake BioPartners Fund I, L.P. for Kyverna Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
735,984 |
|
|
12 Feb 2024 |
Indirect |
|
|
| Series A-1 Redeemable Convertible Preferred Stock |
0 |
|
|
12 Feb 2024 |
Indirect |
Common Stock |
|
| Series A-2 Redeemable Convertible Preferred Stock |
0 |
|
|
12 Feb 2024 |
Indirect |
Common Stock |
|
| Series B Redeemable Convertible Preferred Stock |
0 |
|
|
12 Feb 2024 |
Indirect |
Common Stock |
|
Transactions reported by Westlake BioPartners Fund I, L.P. for Kyverna Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.